Presumably all proteins in vivo, irrespective of their function and location, are undergoing renewal through constant degradative and biosynthetic processes. The regulation of these kinetics are finely adjusted in healthy states and accurately determines protein pool size and function. Research fields attempting to link gene expression, molecular signaling, and protein kinetics regulation as the basis for long-term adaptations in health and disease, therefore, make huge efforts to unwind this complex regulation to improve the understanding of basic physiology and to develop clinical drug-therapy treatments. It is foreseen that protein specificity will be an inevitable demand to move this research up a level [1 ]. Isolation of the most abundant protein fractions from, for example, muscle homogenates with the purpose to study protein synthesis rates has been done for several years [2-4,5 -7 ], and the most recent technical improvements have made the mass spectrometry (MS) analyses possible using very small protein quantities [8,9 ,10 ]. Although available approaches to determine protein synthesis rates are available for the future demands, the existing methods to measure protein breakdown markedly lag behind.
Introduction
Presumably all proteins in vivo, irrespective of their function and location, are undergoing renewal through constant degradative and biosynthetic processes. The regulation of these kinetics are finely adjusted in healthy states and accurately determines protein pool size and function. Research fields attempting to link gene expression, molecular signaling, and protein kinetics regulation as the basis for long-term adaptations in health and disease, therefore, make huge efforts to unwind this complex regulation to improve the understanding of basic physiology and to develop clinical drug-therapy treatments. It is foreseen that protein specificity will be an inevitable demand to move this research up a level [1 ] . Isolation of the most abundant protein fractions from, for example, muscle homogenates with the purpose to study protein synthesis rates has been done for several years [2-4,5 -7 ], and the most recent technical improvements have made the mass spectrometry (MS) analyses possible using very small protein quantities [8,9 ,10 ] . Although available approaches to determine protein synthesis rates are available for the future demands, the existing methods to measure protein breakdown markedly lag behind.
Existing methods to determine protein fractional breakdown rate
Conceptually divergent approaches have been employed for determination of the protein breakdown rate. Being the most applied of the existing approaches, the tracer-dilution principle assumes that any afferent tracer enrichment will be diluted at the efferent site only by the release of analyte from the tissue of interest -a causal consequence of protein breakdown. Basically, two approaches exist to determine the fractional breakdown rate (FBR) of proteins by the tracer-dilution technique. The first and the most used is the free amino acid tracer-dilution approach, in which the amino acid tracer enrichment at the arterial site is compared with that at the venous [11] or tissue-free [12, 13] . Despite that sophisticated refinements have simplified [14, 15 ] and decreased the invasiveness [16] of the method, thereby improving the applicability, the approach cannot determine the breakdown rate of individual or fractions of proteins [17, 18] . Another tracer-dilution approach to assess the breakdown rate of proteins is to trace a specific amino acid, which is released when a certain protein is broken down. According to that approach, the breakdown rate of the myocontractile proteins can be Purpose of review To outline different approaches of how protein breakdown can be quantified and to present a new approach to determine the fractional breakdown rate of individual slow turnover proteins in vivo.
Recent findings
None of the available methods for determining protein breakdown can be used to determine the breakdown rate of specific proteins and, therefore, do not keep up to the preceding methodological demands in physiological research. A newly developed approach to determine the fractional breakdown rate of single proteins seems promising. Its conceptual advantage is that the proteins of interest are the site of measurement. Hence, the application initially demands the proteins to be labeled with stable isotopically labeled amino acids. Subsequently, the loss of label from the proteins will be dependent on the protein breakdown rate when no labeled amino acids are reincorporated into the protein, the protein mass is steady, and when proteins contained in the measured fraction are stochastically selected for degradation.
Summary
Although the synthesis rate of specific proteins can be accurately determined, methodological improvements are required to elucidate the physiological role of protein degradation. The novel approach is promising but future studies are needed to address its wider applicability. studied by measuring the 3-methylhistidine (3-MH) release [19 ,20,21,22 ,23] and collagen degradation can be studied by tracing hydroxyproline or hydroxyglycine [24] . When applied across a limb and traced with stable isotopically labeled metabolites, the approach is both valid and reliable. Although this approach is useful when the myocontractile and collagen proteins are the proteins of interest, the major disadvantage of it is that the assessment of the breakdown rate is limited only to proteins containing such a metabolite that with certainty only originates from one specific protein type, which obviously is reserved for only few proteins and tissues. Alternatively it is well acknowledged that the difference between the fractional synthesis (r s ) and breakdown (r d ) rates equals the net rate of change in the protein mass, that is, r net ¼ r s À r d . Thus, by determining protein synthesis rate and changes in protein mass, the FBR can be calculated. However, a direct sizable comparison of fractional synthesis rate (FSR) and changes in protein mass appears not to be validly done, as the FSR is determined over short periods (minutes to hours), whereas often several days are necessary to determine changes in protein mass solidly [25, 26] . Therefore, the measured r net is the average change in protein mass across a period of time that is several-fold longer than that the synthesis rate is determined across, which makes the latter more dependent on actual behavioral and environmental stimuli. Thus, a direct comparison may be invalid. Furthermore, determining total tissue protein mass or single protein concentration is conceptually connected with problems concerning accuracy and choice of reference. Although applied in physiological trials [27, 28] , this approach has never really had its breakthrough in in-vivo studies of larger animals and humans. A direct measure of protein breakdown rate can be determined during protein steady-state conditions, applying models described more than 30 years ago [29] . By prelabeling proteins with tracer, the subsequent disappearance of tracer from the media will follow a first-order decay, provided that no tracer is reincorporated [30] and total protein mass is maintained. These required conditions might be readily controlled in cell and bacteria cultures to reveal valid results on protein breakdown rates [31] [32] [33] , whereas it may be harder in larger animals in vivo [34] . The outlined disadvantages are: long tracer labeling times, problems with tracer recirculation, and protein mass steady state.
Protein-specific fractional breakdown rate of prelabeled proteins
With reference to the strength of the direct incorporation approach for the determination of protein synthesis, it is our impression that the proteins must be the final endpoint for the measurement forming the basis for the calculation of the fractional protein breakdown rate. Thus, despite the described challenges and limitations with the latter method mentioned above, we here present a newly developed approach to determine the FBR of individual proteins applicable in larger animals in vivo. The principle is similar to that described earlier, that is, based on the disappearance of a protein-bound stable isotopically labeled amino acid that prior to the actual measurements was incorporated into the protein of interest [35 ] .
Prelabeling of proteins
A sufficient labeling of proteins via incorporation of stable isotopically labeled amino acids is easily obtained by oral administration of deuterium-labeled water, 2 H 2 O. Labeling with any other atom prebound to an amino acid (either 2 H, 13 C, or 15 N) can be done sufficiently only by prolonged continuous infusion or multiple floodings that would become too complicated and expensive to perform. Water is by many means very applicable for this purpose and has previously been shown reliably and quickly to label amino acids [34, [36] [37] [38] (see Fig. 1 ). Water serves as an intermediate in the metabolic equilibration between amino acids and their ketoacids as well as a hydrogen donor in the tricarboxylic acid-cycle synthesizing precursors for some amino acids. The amino acid precursor pool can thereby be maintained at an adequate enrichment by oral administration of one or more boluses of deuterium oxide or by replacing a fraction of the drinking water with deuterium oxide (Fig. 1) . Additionally, because of the relatively low turnover rate of water and thus the slow disappearance rate as compared with that of free amino acids, the labeled amino acids remain in the protein precursor pool for an extended period of time after withdrawal of the labeled water (Figs 1 and 2). Therefore, labeling of even slow turnover proteins with 2 H-labeled amino acids can be obtained by administration of deuterium oxide. Alanine can exchange up to four deuteriums with water in vivo, which improves the analytical sensitivity of alanine as compared with other amino acids (see isotope ratio in Fig. 1 ).
Principle in approach to measure fractional breakdown rate by a novel method Briefly, the practical approach is a multistep setup that is illustrated in Figs 1 and 2.
Step 1, prelabeling of proteins of interest via oral administration of deuterium-labeled water. On the basis of existing values on protein synthesis rates, the amount and necessary time for deuterium oxide labeling can be estimated.
Step 2, withdrawal of deuterium oxide and return to plain tap water to allow washout of label from the precursor pool.
Step 3, after a sufficient period (>3 half-lives of water, i.e., <10% of peak enrichment) on unlabeled water, the deuterium has disappeared from water, tightly followed by the free amino acids, and thus the protein precursor pool. For this purpose, alanine is especially suitable because it follows the drop in water enrichment more tightly than other amino acids ( Fig. 1 ). When this condition is established, no reincorporation of deuterium-labeled amino acids into proteins takes place.
Step 4, at this point in time, the proteins will lose the deuterium-labeled amino acids at a rate dependent only on the breakdown rate of the proteins. The mathematical derivation of the relationship is briefly outlined below, where P and P Ã are the total proteins and labeled proteins, respectively. The dot ( ) denotes differentiation with respect to time. k d is the rate constant of degradation (d) and r net is the net rate of tissue protein accretion/loss (i.e. the difference between synthesis and breakdown rates).
528 Assessment of nutritional status and analytical methods The model is based on human fasting turnover rates of skeletal muscle and connective tissue proteins (0.7%/day) and body water (9%/day). It is obvious from the illustration that the water and thus free amino acid precursor pool enrichment is higher than the protein-bound amino acid due to the huge differences between turnover rates. Not until after 30 days does the precursor enrichment drop to a level lower than the protein-bound amino acids, that is, first from this point in time does a net loss of deuteriumlabeledaminoacids takeplace fromthe protein-bound pool. AA, aminoacid.
Figure 1 Sample isotope ratio subtracted the background isotope ratio and enrichments [E, calculated as (sample isotope ratio S background isotope ratio)/number of deuterium labels] of three serum-free amino acids: alanine, valine, and serine and serum water from 4-10 rats administered 8 vol% 2 H 2 O in their drinking water for 42 days from the age of approximately 4 weeks After 42 days, the deuterium-labeled water was withdrawn from the drinking water and the rats continued on plain tap water. The amino acids isotope ratio (IR) values inhere the likelihood of finding one heavier isotope on the amino acid, that is, an IR twice the enrichment value (serine) means that two deuteriums are incorporated, whereas an IR almost four times the enrichment (alanine) means four possible sites for hydrogens to be exchanged with deuterium in vivo.
The loss of deuterium label on alanine closely follows the disappearance of deuterium label in water, whereas the label remains longer on valine and serine. This means that alanine turnover is faster than the other two amino acids. Values are mean AE SD. ( ) Water E, ( ) alanine E, ( ) valine E, (
) serine E, ( ) alanine sample IR À background IR, ( ) valine sample IR À background IR, ( ) serine sample IR À background IR.
As it is the case for determination of the FSR [39] , a steady protein mass is required during these experiments as well [29, 31, 40] . When the protein mass rightly can be assumed to be unchanged over the course of the FBR assessment (r net ¼ 0), the change in protein enrichment is described by the monoexponential decay with the FBR, k d , as the disappearance rate:
Assumptions and considerations for the fractional breakdown rate approach Currently, only data obtained in rats have been reported using this approach [34, 35 ] . For human application, it cannot be ethically approved to enrich body water to the same extent as in animals [34, 36, 41] , and additionally because of the applicability of the approach, the labeling period will probably be inadequate to allow precursor and slow turnover protein enrichments to equilibrate. Taken together, human protein labeling is very limited compared with existing animal data. However, because of the relatively slow turnover rate of water, the deuterium remains in the in-vivo system for some time after return to tap water. Therefore, slow turnover proteins will be labeled over many days after just a single loading dose of deuterium oxide (Fig. 2 ). Giving only one bolus of deuterium oxide, enriching body water and thus free amino acids with 0.5-1.0% deuterium, the slowest turnover body proteins ($1%/day, such as muscle contractile and connective tissue collagen proteins) will be enriched up till about one-tenth of that of the precursor pool (Fig. 2) . Subsequently, when the labeling has disappeared from the precursor pool, it will demand several days to detect a difference in protein labeling due to breakdown of approximately 1%/day with the sensitivity of the available equipment [gas chromatography (GC)/ mass spectrometry (MS)/MS electron ionization mode and GC/pyrolysis/isotope ratio mass spectrometry (IRMS)]. Thus, the FBR can only be determined as a mean over several days, whereas the FSR determination in comparison can be completed within hours. Therefore, a direct comparison of FSR and FBR in absolute values should be avoided. However, the values are assessed independently and thus can be discussed as individual 
Venous site
From capillary vessels, the free amino acids diffuse across the interstitial space and are transported into the cytoplasm. Here, the amino acids undergo enzymatic transamination (TA) are involved in the phosphoenolpyruvate carboxykinase (PEP-CK) reaction. Alanine is de-novo synthesized via the tricaboxylic acid cycle and serine and glycine are in equilibrium via serine tetrahydrofolate methyl transferase (STHM). In these reactions water is involved as a donor of hydrogen by which processes the deuteriums are exchanged into the amino acids. A, The deuterium-labeled amino acids then charge the tRNAs, which subsequently, B, deliver the amino acids to the ribosomes synthesizing new peptides. C, The terminated peptide chain is released as a preprotein, D, that must undergo some kind of modification before it can obtain full functionality. E, Exocytosis, translocation, and/or incorporation of protein to its functional location that may be extracellular. F, Presumable at every stage, the peptide/protein can be targeted for degradation and the likelihood for this to happen and hence the breakdown rate, is illustrated by the number of arrows pointing into the site of degradation (scissor). The degradation of proteins releases free amino acids into the cytoplasm, where the deuterium label will equilibrate with the present enrichment in water. Any amino acids entering the cytoplasm with excess deuterium label will therefore equilibrate with the water enrichment via the enzymatic reactions. Therefore, it can presumable be correctly assumed that the deuterium label of free amino acids in the precursor pool at any point in time is similar to the deuterium enrichment of body water.
measures. They are not in conflict with one another as was the case in the previously mentioned approach solving r d ¼ r s À r net . Independent of experimental setups, the designs should be set up so that the FBR reflect a chronic, weighted average value across the intervention period. In comparison, the FSR values may reflect more acute conditions and its measurement should preferably be repeated at various timepoints throughout the FBR intervention period to generate a similar 'weighted mean' comparable to the FBR value.
Although a steady protein mass is fundamental for both the FSR and FBR approaches, it is more important to consider in the FBR approach, as the intervention period is several days as compared with hours for the FSR. Thus, future interventions must be adjusted accordingly not to violate this assumption. Also, as it is the case for the FSR measurement, no tracer recirculation must take place during the FBR intervention period. Although this assumption is met in terms of no label in the precursor pool, proteins containing labeled amino acids will continuously release those into the free intracellular space. Therefore, it is of most importance that the label is removed from the amino acid before it may be reutilized to charge another tRNA and thereby recircle (illustrated in Fig. 3 ). Alanine has been shown to equilibrate with water deuterium enrichment within minutes [36] and faster than other amino acids (Fig. 1) , which is why alanine is especially suitable as a tracer for this FBR approach.
Maturity of proteins: important for both synthesis and breakdown
In approaches in which the proteins are the site of measurement, the complexity of the protein kinetic processes should be acknowledged (Fig. 3) . During production of a new and functionally active protein, the first step is the translation of the mRNA into a peptide chain. Already at this step, the stable isotopically labeled amino acid tracer appears in the preprotein. However, multiple post-translational events often occur to form a stable and functional protein. The amount of labeled amino acids at a certain point in time will depend on the synthesis rate of any specific sub-protein pool. It is well known that the synthesis rate of different pools of the same proteins differs several-fold [32, 42] . When isolating the protein (pool) of interest for assessment of the FSR, it is, therefore, of most importance that the protein fraction is homogenous in terms of the protein maturity, that is, state of post-translational modification. Of similar importance, is it also crucial that the proteins for determination of the FBR originate from the same sub-pool of proteins. Further, the basis for the breakdown approach is that the protein, selected for degradation, is targeted randomly. When protein at different maturity stages inhere diver-gent turnover rates, a stochastic selection of proteins for breakdown can only to be met within proteins belonging to the same level of maturity. Therefore, cross-contaminations between protein maturity pools will invalidate the assessed enrichment irrespective of synthesis or breakdown rates.
Conclusion
The range of possible applications of the just described FBR approach is wide. The future challenge will be to apply physiological interventions that on the one hand can be assumed not to induce marked changes in protein mass over the course of the FBR determination period, but on the other, apply enough stimulus to study its impact. No natural occurring condition whether it is nutritional, physical activity, or hormonal results in severe changes that affect protein mass significantly within a few days. However, detrimental interventions such as administration of superphysiological hormone levels, critical illness, and immobilization may inhere the impact of fast and marked changes in protein mass. Future studies and forthcoming pilot studies must appreciate the efforts to reveal the nature of acute adaptation and correct study designs accordingly.
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